NGS DNA Mutation Analysis
Asuragen now offers comprehensive targeted DNA mutation analysis of tumor samples using next generation sequencing to identify both known and de novo mutations within FFPE and FNA specimens. Services will include both Asuragen’s SuraSeq™ custom cancer panels and the Ion AmpliSeq™ cancer panel.
More information coming soon. For additional information, please contact Diane Ilsley, Genomic Services Marketing Manager, at dilsley@asuragen.com
Webinar:
Next Generation Sequencing of FFPE Samples
Dr. Gary Latham
Director of Diagnostic Research and Technology Development
Click Here to View this Webinar